Loading
Latest filing published 22 Apr 2021 for GenMark Diagnostics, Inc., €1.0M.
No signal scores available.
Wade R. Stevenson discloses dealings in GenMark Diagnostics, Inc. to SEC (Form 4). The record holds 2 filings, for trades running from 9 April 2021 to 22 April 2021.
The filings describe grants, exercises and other transfers rather than trades on the open market. Compensation-driven entries like these are tracked, but they say little about how insiders judge the share price.
The newest entry dates from 22 April 2021: a transaction of €1.0M, in GenMark Diagnostics, Inc. This summary is built from SEC (Form 4) disclosures alone and does not predict where the share price will go.
Open company profiles for insider transactions, fundamentals and analyst consensus when available.
2 of 2 declarations